Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review

• Main Authors: Maria Erika G. Ramirez, Joanne M. Bargman
• Format: Article
• Language: English
• Published: Elsevier 2017-09-01
• Series: Journal of Advanced Research
• Subjects: Uric acid; Chronic kidney disease; Hyperuricemia; Allopurinol
• Online Access: http://www.sciencedirect.com/science/article/pii/S2090123217300516

Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function.